• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺眼病中眼外肌增大的容积分析

Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis.

作者信息

Park Kristen, Li Joy, Wen Joyce, Li Shirley, Lee Jonathan, Danesh Kayla, Malkoff Nicolas, Gokoffski Kimberly, Lerner Alexander, Patel Vishal, Zhang-Nunes Sandy, Chang Jessica

机构信息

Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, USA.

University of Southern California (USC) Roski Eye Institute, Keck School Medicine, University of Southern California, Los Angeles, USA.

出版信息

Cureus. 2024 Jul 4;16(7):e63843. doi: 10.7759/cureus.63843. eCollection 2024 Jul.

DOI:10.7759/cureus.63843
PMID:39105029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11298761/
Abstract

BACKGROUND AND OBJECTIVES

It is commonly taught that thyroid eye disease (TED) causes enlargement of the extraocular muscles (EOMs) in the following descending order: inferior rectus (IR), medial rectus (MR), superior rectus (SR), lateral rectus (LR), superior oblique (SO) and inferior oblique (IO). However, with recent literature challenging this notion, we aimed to compare EOM volumes in our cohort of TED patients.  Methods: We conducted a retrospective, non-randomized case-control study. Twenty-eight orbits from 28 unique patients with TED who had high-resolution CT scans were compared to 31 normal orbits, all from a single academic institution. Orbital soft tissues were manually segmented using ITK-SNAP 3.8.0 (http://itksnap.org), and soft tissue volumes of the control and TED orbits were compared using independent-sample t-tests.

RESULTS

Of the TED orbits, 54% of SR/levator palpebrae superioris complex volumes (SRC) and 50% of IR volumes were greater than two standard deviations above the normal orbit average. Compared to controls, the mean SRC volume in TED subjects was 2.3 times enlarged, followed by the IR (2.1 times), SO (1.8 times), MR (1.7 times), LR (1.6 times), IO (1.6 times), and orbital fat (1.4 times) ( < 0.01 for all).  Conclusions: Our findings suggest that contrary to previous teaching, the SRC may be the most severely affected in TED.

摘要

背景与目的

通常认为甲状腺眼病(TED)会导致眼外肌(EOMs)按以下降序增大:下直肌(IR)、内直肌(MR)、上直肌(SR)、外直肌(LR)、上斜肌(SO)和下斜肌(IO)。然而,随着近期文献对这一观点提出质疑,我们旨在比较我们队列中TED患者的眼外肌体积。方法:我们进行了一项回顾性、非随机病例对照研究。将来自28例接受高分辨率CT扫描的TED患者的28个眼眶与来自同一学术机构的31个正常眼眶进行比较。使用ITK-SNAP 3.8.0(http://itksnap.org)手动分割眼眶软组织,并使用独立样本t检验比较对照组和TED眼眶的软组织体积。结果:在TED眼眶中,54%的上直肌/上睑提肌复合体体积(SRC)和50%的下直肌体积比正常眼眶平均值高出两个标准差以上。与对照组相比,TED受试者的平均SRC体积增大了2.3倍,其次是下直肌(2.1倍)、上斜肌(1.8倍)、内直肌(1.7倍)、外直肌(1.6倍)、下斜肌(1.6倍)和眼眶脂肪(1.4倍)(所有P<0.01)。结论:我们的研究结果表明,与先前的观点相反,SRC在TED中可能受影响最严重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/8187d4d8ddb8/cureus-0016-00000063843-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/8e5d62d37491/cureus-0016-00000063843-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/2d2b4d6907e2/cureus-0016-00000063843-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/8187d4d8ddb8/cureus-0016-00000063843-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/8e5d62d37491/cureus-0016-00000063843-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/2d2b4d6907e2/cureus-0016-00000063843-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d518/11298761/8187d4d8ddb8/cureus-0016-00000063843-i03.jpg

相似文献

1
Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis.甲状腺眼病中眼外肌增大的容积分析
Cureus. 2024 Jul 4;16(7):e63843. doi: 10.7759/cureus.63843. eCollection 2024 Jul.
2
Extraocular muscle enlargement in dysthyroid optic neuropathy.甲状腺相关眼病性视神经病变中的眼外肌肿大。
Can J Ophthalmol. 2024 Oct;59(5):e542-e546. doi: 10.1016/j.jcjo.2023.11.015. Epub 2023 Dec 16.
3
Investigation of lacrimal gland and extraocular muscle in thyroid eye disease patients with severe subjective dry eye disease: a multiparametric magnetic resonance imaging study.甲状腺眼病患者严重主观干眼症的泪腺和眼外肌的研究:一项多参数磁共振成像研究。
Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2651-2659. doi: 10.1007/s00417-024-06424-x. Epub 2024 Mar 8.
4
Predominant Contribution of Superior Rectus-Levator Complex Enlargement to Optic Neuropathy and Inferior Visual Field Defects in Thyroid Eye Disease.甲状腺眼病中,上直肌-提肌复合体增大对视神经病变和下视野缺损的主要影响。
Ophthalmic Plast Reconstr Surg. 2019 May/Jun;35(3):262-265. doi: 10.1097/IOP.0000000000001224.
5
Correlation between extraocular muscle size and motility restriction in thyroid eye disease.甲状腺眼病中外直肌大小与运动受限的相关性。
Ophthalmic Plast Reconstr Surg. 2011 Mar-Apr;27(2):102-10. doi: 10.1097/IOP.0b013e3181e9a063.
6
Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease.甲状腺眼病中外眼肌脂肪浸润的影像学分析。
Orbit. 2022 Feb;41(1):53-58. doi: 10.1080/01676830.2020.1817100. Epub 2020 Sep 2.
7
Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease.计算机断层扫描测量的眼外肌大小与甲状腺眼病垂直偏斜角度之间的相关性
PLoS One. 2016 Jan 28;11(1):e0148167. doi: 10.1371/journal.pone.0148167. eCollection 2016.
8
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.特普瑞单抗可减少甲状腺眼病的眼外肌和眶脂肪体积。
Br J Ophthalmol. 2022 Feb;106(2):165-171. doi: 10.1136/bjophthalmol-2020-317806. Epub 2020 Nov 10.
9
Radiographic analysis of extraocular muscle volumetric changes in thyroid-related orbitopathy following orbital decompression.甲状腺相关眼病眶减压术后眼外肌容积变化的影像学分析。
Ophthalmic Plast Reconstr Surg. 2010 Jan-Feb;26(1):1-6. doi: 10.1097/IOP.0b013e3181b80fae.
10
Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.甲状腺眼病所致甲状腺功能亢进性视神经病变的视野与眼眶 CT 相关性。
Orbit. 2020 Apr;39(2):77-83. doi: 10.1080/01676830.2019.1600150. Epub 2019 May 6.

本文引用的文献

1
The Effect of Teprotumumab on Eyelid Position in Patients with Thyroid Eye Disease.替普罗单抗对甲状腺眼病患者眼睑位置的影响。
Plast Reconstr Surg Glob Open. 2022 Apr 22;10(4):e4287. doi: 10.1097/GOX.0000000000004287. eCollection 2022 Apr.
2
Management of eyelid retraction related to thyroid eye disease.甲状腺眼病相关眼睑退缩的管理
Taiwan J Ophthalmol. 2022 Feb 14;12(1):12-21. doi: 10.4103/tjo.tjo_57_21. eCollection 2022 Jan-Mar.
3
Age-related difference in extraocular muscles and its relation to clinical manifestations in an ethnically homogenous group of patients with Graves' orbitopathy.
在一组种族同质的格雷夫斯眼眶病患者中眼外肌的年龄相关差异及其与临床表现的关系。
Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):583-589. doi: 10.1007/s00417-021-05377-9. Epub 2021 Sep 3.
4
Thyroid eye disease: Redefining its management-A review.甲状腺眼病:重新定义其治疗策略——综述
Clin Exp Ophthalmol. 2021 Mar;49(2):203-211. doi: 10.1111/ceo.13899. Epub 2021 Jan 22.
5
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.特普瑞单抗可减少甲状腺眼病的眼外肌和眶脂肪体积。
Br J Ophthalmol. 2022 Feb;106(2):165-171. doi: 10.1136/bjophthalmol-2020-317806. Epub 2020 Nov 10.
6
Superior oblique enlargement in thyroid eye disease.甲状腺眼病中的上斜肌增粗。
J AAPOS. 2019 Oct;23(5):252.e1-252.e4. doi: 10.1016/j.jaapos.2019.04.010. Epub 2019 Jul 22.
7
Thyroid eye disease presenting with superior rectus/levator complex enlargement.表现为上直肌/提上睑肌复合体增大的甲状腺眼病。
Orbit. 2020 Feb;39(1):5-12. doi: 10.1080/01676830.2019.1594969. Epub 2019 May 6.
8
Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.Graves眼病单侧上睑退缩患者眼睑位置与提上睑肌-上直肌复合体及下直肌之间的关系
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):2001-2008. doi: 10.1007/s00417-018-4056-z. Epub 2018 Jun 29.
9
Anatomic Considerations in Thyroid Eye Disease.甲状腺眼病的解剖学考量
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S7-S12. doi: 10.1097/IOP.0000000000001122.
10
Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).甲状腺眼病(TED)眼睑退缩的非手术治疗
Br J Ophthalmol. 2017 Aug 9. doi: 10.1136/bjophthalmol-2017-310695.